These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 15315866

  • 1. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [Abstract] [Full Text] [Related]

  • 2. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Sep; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 3. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 4. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA, Kulkarni KD.
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [Abstract] [Full Text] [Related]

  • 5. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C.
    Diabetes Educ; 2006 Apr; 32(3):423-32. PubMed ID: 16772658
    [Abstract] [Full Text] [Related]

  • 6. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D, Yanagisawa RT.
    Med Clin North Am; 2007 Nov; 91(6):1107-23, ix. PubMed ID: 17964912
    [Abstract] [Full Text] [Related]

  • 7. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Nov; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 8. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 10. The elderly and diabetes: an age trend and an epidemic converging.
    Marquess JG.
    Consult Pharm; 2008 Apr 28; 23 Suppl B():5-11. PubMed ID: 18540787
    [Abstract] [Full Text] [Related]

  • 11. The stepwise approach to the management of type 2 diabetes.
    Warren RE.
    Diabetes Res Clin Pract; 2004 Sep 28; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [Abstract] [Full Text] [Related]

  • 12. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
    Pi-Sunyer FX.
    Postgrad Med; 2008 Jul 28; 120(2):5-17. PubMed ID: 18654064
    [Abstract] [Full Text] [Related]

  • 13. Recognizing the rising impact of diabetes in seniors and implications for its management.
    Drab SR.
    Consult Pharm; 2009 Jun 28; 24 Suppl B():5-10. PubMed ID: 19555130
    [Abstract] [Full Text] [Related]

  • 14. [Management of children and adolescents with diabetes mellitus: personal experience].
    Dorchy H.
    Rev Med Brux; 2005 Sep 28; 26(4):S246-54. PubMed ID: 16240870
    [Abstract] [Full Text] [Related]

  • 15. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ.
    Curr Med Res Opin; 2004 Apr 28; 20(4):541-53. PubMed ID: 15119992
    [Abstract] [Full Text] [Related]

  • 16. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G.
    J Diabetes Complications; 2005 Apr 28; 19(3):168-77. PubMed ID: 15866064
    [Abstract] [Full Text] [Related]

  • 17. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM, Praet SF, van den Broek NM, Kuipers H, Stehouwer CD, Nicolay K, Prompers JJ, van Loon LJ.
    Diabetes Care; 2007 Oct 28; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract] [Full Text] [Related]

  • 18. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.
    J Diabetes Complications; 2007 Oct 28; 21(1):20-7. PubMed ID: 17189870
    [Abstract] [Full Text] [Related]

  • 19. Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review.
    Dailey G.
    Curr Med Res Opin; 2004 Dec 28; 20(12):2007-14. PubMed ID: 15701217
    [Abstract] [Full Text] [Related]

  • 20. Use of insulin and weight gain: optimizing diabetes nutrition therapy.
    Daly A.
    J Am Diet Assoc; 2007 Aug 28; 107(8):1386-93. PubMed ID: 17659906
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.